Inflammatory leptomeningeal cytokines mediate COVID-19 neurologic symptoms in cancer patients. Remsik, Wilcox et al.

Published: 7 January 2021| Version 1 | DOI: 10.17632/s7m535k6nt.1
Contributor:
Jan Remsik

Description

Targeted proteomics analyses of cerebrospinal fluid from four patient cohorts, as described in Remsik, Wilcox et al.

Files